Abstract:This study uses Monte Carlo simulation and experimental measurements to develop a predictive model for estimating the external dose rate associated with permanent radioactive source implantation in prostate cancer patients. The objective is to estimate the accuracy of the patient's external dose rate measurement. First, I-125 radioactive sources were implanted into Mylar window water phantoms to simulate the permanent implantation of these sources in patients. Water phantom experimental measurement was combined with Monte Carlo simulation to develop predictive equations, whose performance was verified against external clinical data. The model's accuracy in predicting the external dose rate in patients with permanently implanted I-125 radioactive sources was high (R2 = 0.999). A comparative analysis of the experimental measurements and the Monte Carlo simulations revealed that the maximum discrepancy between the measured and calculated values for the water phantom was less than 5.00%. The model is practical for radiation safety assessments, enabling the evaluation of radiation exposure risks to individuals around patients with permanently implanted I-125 radioactive sources.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to accurately assess and predict the radiation dose rate in the patient's surrounding environment when using I - 125 permanent radioactive source implantation in the treatment of prostate cancer, so as to ensure compliance with radiation safety guidelines. Specifically, the research objectives are: 1. **Verify the accuracy of measurement and Monte Carlo simulation**: Through experimental measurement and Monte Carlo simulation, verify the accuracy between the measured value and the simulated value of the environmental dose equivalent \(H^*(10)\) outside the water phantom. 2. **Develop a prediction model**: Based on the results of Monte Carlo simulation, develop a set of equation models for predicting the effective dose of the patient's family members or the public after the patient is implanted with a radioactive source. ### Research Background - **Prostate cancer treatment**: Prostate cancer is one of the most common cancers in men. Treatment methods include low - dose - rate (LDR) permanent implant brachytherapy, high - dose - rate (HDR) temporary brachytherapy, external beam radiotherapy (EBRT) and radical prostatectomy (RP). - **I - 125 permanent implant brachytherapy**: The I - 125 radioisotope is often used for permanent implant treatment of local prostate cancer, which can significantly reduce the dose outside the implant area, protect at - risk organs such as the rectum and bladder, reduce side effects, and enable patients to recover more quickly. - **Radiation safety assessment**: After implanting a radioactive source, it is necessary to assess the radiation exposure dose of the people around the patient to ensure that it complies with the recommended standards of the International Commission on Radiological Protection (ICRP), the National Council on Radiation Protection and Measurements (NCRP) and the United States Nuclear Regulatory Commission (NRC). For example, the effective dose of caregivers should not exceed 5 mSv/year, and the effective dose of the public should not exceed 1 mSv/year. ### Research Methods - **Experimental measurement**: Use 30 I - 125 radioactive sources and place them in a Mylar - windowed water phantom to measure the environmental dose equivalent \(H^*(10)\) at different distances. - **Monte Carlo simulation**: Use the PHITS code for simulation. The simulation geometric conditions are consistent with the actual measurement conditions to construct a prediction model. - **Clinical data verification**: Use the clinical data of 21 patients implanted with I - 125 radioactive sources to verify the accuracy of the prediction model. ### Main Results - **Model accuracy**: The maximum difference between the predicted value of \(H^*(10)\) at different distances by the prediction model and the actual measured value is less than 5.00%, and the \(R^2\) value of the model is as high as 0.999. - **Clinical verification**: The differences between the measured values and the predicted values of \(H^*(10)\) at 0 cm, 30 cm and 100 cm are all within 5.00%. ### Conclusion The prediction model in this study can accurately predict the radiation dose rate in the surrounding environment of prostate cancer patients implanted with I - 125 radioactive sources, with an error of less than 10%. This model is helpful for radiation safety assessment, ensuring that the radiation exposure doses of the patient's family members and the public meet the ALARA standard, and thus effectively guiding the radiation protection measures for prostate brachytherapy patients.

Radiation Safety Assessment in Prostate Cancer Treatment: A Predictive Approach for I-125 Brachytherapy

Radiation levels outside a patient undergoing 177Lu-PSMA radioligand therapy

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

Feasibility of internal-source tracking with C-arm CT/SPECT imaging with limited-angle projection data for online in vivo dose verification in brachytherapy: A Monte Carlo simulation study

[Simulation of dose distribution in bone medium of 125I photon emitting source with Monte Carlo method].

A torus source and its application for non-primary radiation evaluation

Validation of a Deep Learning-Based Material Estimation Model for Monte Carlo Dose Calculation in Proton Therapy.

Dosimetric investigation of 103Pd permanent breast seed implant brachytherapy based on Monte Carlo calculations

A Clinical Monte Carlo Dosimetric Evaluation in Accelerated Partial Breast Electronic Brachytherapy

Simulation, Visualization and Dosimetric Validation of Scatter Radiation Distribution under Fluoroscopy Settings

Real-time definition of single seed placement sensitivity in low-dose-rate prostate brachytherapy

Deep learning-based dose map prediction for high-dose-rate brachytherapy

Preliminary study of correction of original metal artifacts due to 1-125 seeds in postimplant dosimetry for prostate permanent implant brachytherapy

Calculations of beta radiation doses from multiwell Phosphorus-32 and Yttrium-90 applicators designed to be used in the treatment of superficial skin tumors: comparison of Monte Carlo and analytical methods

Sensitivity analysis of biological washout and depth selection for a machine learning based dose verification framework in proton therapy

Monte Carlo Calculations of the Dosimetry Parameters for the 125I Brachytherapy Source

Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy

Evaluation of an automated clinical decision system with deep learning dose prediction and NTCP model for prostate cancer proton therapy

Feasibility of using micro silica bead TLDs for in-Vivo dosimetry of CT-based HDR prostate brachytherapy: An experimental and simulation study

Internal Dosimetry Assessment of Beta, Beta/Auger, and Alpha Decaying Radionuclidesin Targeted Radionuclide Therapy for Prostate Cancer: A Simulation Study

SU-GG-T-347: Methods to Calculate Organ Doses Due to Scattered Radiation From External Beam Radiation Treatment Using Various Patient Phantoms and Monte Carlo Simulations